Zhong Chao Han
Chairman at Tianjin Amcellgene Engineering Co., Ltd.
Profile
Zhong Chao Han is currently the Chairman & Chief Scientist of Tianjin Amcellgene Engineering Co., Ltd.
and the Chairman of Beijing Health & Biotech Co., Ltd.
Zhong Chao Han active positions
Companies | Position | Start |
---|---|---|
Tianjin Amcellgene Engineering Co., Ltd.
Tianjin Amcellgene Engineering Co., Ltd. BiotechnologyHealth Technology Tianjin Amcellgene Engineering Co., Ltd. engages in the research and development of cell therapeutic products. It offers human adipose-derived, human umbilical cord, and human amniotic membrane-derived mesenchymal stem cells. The company was founded in August 2004 and is headquartered in Tianjin, China. | Chairman | - |
Beijing Health & Biotech Co., Ltd.
Beijing Health & Biotech Co., Ltd. BiotechnologyHealth Technology Beijing Health & Biotech Co., Ltd. engages in the development of stem cell technologies. Its business offers diabetes therapy, cardiovascular diseases therapy, neurological diseases therapy, autoimmune diseases therapy, limb ischemic disease therapy, sub-health and anti-aging therapy, and stem cell banking. The company was founded on January 8, 2007 and is headquartered in Beijing, China. | Chairman | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Tianjin Amcellgene Engineering Co., Ltd.
Tianjin Amcellgene Engineering Co., Ltd. BiotechnologyHealth Technology Tianjin Amcellgene Engineering Co., Ltd. engages in the research and development of cell therapeutic products. It offers human adipose-derived, human umbilical cord, and human amniotic membrane-derived mesenchymal stem cells. The company was founded in August 2004 and is headquartered in Tianjin, China. | Health Technology |
Beijing Health & Biotech Co., Ltd.
Beijing Health & Biotech Co., Ltd. BiotechnologyHealth Technology Beijing Health & Biotech Co., Ltd. engages in the development of stem cell technologies. Its business offers diabetes therapy, cardiovascular diseases therapy, neurological diseases therapy, autoimmune diseases therapy, limb ischemic disease therapy, sub-health and anti-aging therapy, and stem cell banking. The company was founded on January 8, 2007 and is headquartered in Beijing, China. | Health Technology |
- Stock Market
- Insiders
- Zhong Chao Han